Benchmark Holdings PLC - Worthing, England-based aquaculture biotechnology - Pretax loss from continuing operations narrows to £12.7 million in financial year that ended September 30 from a restated £21.4 million the year before, as revenue rises by 7.4% to £169.5 million from £157.7 million. In addition to more money coming in, net finance costs are reduced to £7.7 million from £15.2 million. Ends September with £65.5 million in net debt, down from £73.7 million a year before.

Revenue in largest business area, Advanced Nutrition, declines by 2.2% to £78.5 million in recent year. Benchmark says shrimp market has been challenging, but it now is seeing early indications of improvement. More positively, Genetics revenue increases by 14% to £65.5 million, and Animal Health revenue by 27% to £25.5 million. Benchmark says the new financial year has started well, with positive momentum in all three business lines.

Current stock price: 35.94 pence, up 2.1% in London on Wednesday

12-month change: down 4.2%

Copyright 2023 Alliance News Ltd. All Rights Reserved.